These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31018838)

  • 1. Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years.
    Zeng J; Zhang X; Sun C; Pan Q; Lu WY; Chen Q; Huang LS; Fan JG
    BMC Pediatr; 2019 Apr; 19(1):129. PubMed ID: 31018838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining values for controlled attenuation parameter and liver stiffness in youth without liver disease.
    Ramírez-Vélez R; García-Hermoso A; Correa-Rodríguez M; Izquierdo M
    Pediatr Res; 2022 Mar; 91(4):912-920. PubMed ID: 33846557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient Elastography-Based Liver Stiffness Age-Dependently Increases in Children.
    Tokuhara D; Cho Y; Shintaku H
    PLoS One; 2016; 11(11):e0166683. PubMed ID: 27861607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease.
    Pradhan F; Ladak F; Tracey J; Crotty P; Myers RP
    Ann Hepatol; 2013; 12(1):100-7. PubMed ID: 23293200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis.
    Kwon YD; Ko KO; Lim JW; Cheon EJ; Song YH; Yoon JM
    J Korean Med Sci; 2019 Jun; 34(23):e165. PubMed ID: 31197983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric percentiles for transient elastography measurements - effects of age, sex, weight status and pubertal stage.
    Brunnert L; Puasa ID; Garten A; Penke M; Gaul S; Grafe N; Karlas T; Kiess W; Flemming G; Vogel M
    Front Endocrinol (Lausanne); 2022; 13():1030809. PubMed ID: 36237190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study and control values of transient elastography in healthy children.
    Engelmann G; Gebhardt C; Wenning D; Wühl E; Hoffmann GF; Selmi B; Grulich-Henn J; Schenk JP; Teufel U
    Eur J Pediatr; 2012 Feb; 171(2):353-60. PubMed ID: 21861093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.
    Shen F; Zheng RD; Mi YQ; Wang XY; Pan Q; Chen GY; Cao HX; Chen ML; Xu L; Chen JN; Cao Y; Zhang RN; Xu LM; Fan JG
    World J Gastroenterol; 2014 Apr; 20(16):4702-11. PubMed ID: 24782622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
    Yu XY; Song XX; Tong YL; Wu LY; Song ZY
    Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations.
    Pang JX; Pradhan F; Zimmer S; Niu S; Crotty P; Tracey J; Schneider C; Heitman SJ; Kaplan GG; Swain MG; Myers RP
    Can J Gastroenterol Hepatol; 2014 Mar; 28(3):143-9. PubMed ID: 24619636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.
    Rout G; Nayak B; Patel AH; Gunjan D; Singh V; Kedia S; Shalimar
    J Clin Exp Hepatol; 2019; 9(2):207-214. PubMed ID: 31024203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.
    Demir M; Deyneli O; Yılmaz Y
    Turk J Gastroenterol; 2019 Mar; 30(3):266-270. PubMed ID: 30411703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe.
    Wong GL; Vergniol J; Lo P; Wai-Sun Wong V; Foucher J; Le Bail B; Choi PC; Chermak F; Leung KS; Merrouche W; Chan HL; de Lédinghen V
    Ann Hepatol; 2013; 12(4):570-80. PubMed ID: 23813135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan.
    Cho Y; Tokuhara D; Morikawa H; Kuwae Y; Hayashi E; Hirose M; Hamazaki T; Tanaka A; Kawamura T; Kawada N; Shintaku H
    PLoS One; 2015; 10(9):e0137239. PubMed ID: 26398109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.
    Shen F; Zheng RD; Shi JP; Mi YQ; Chen GF; Hu X; Liu YG; Wang XY; Pan Q; Chen GY; Chen JN; Xu L; Zhang RN; Xu LM; Fan JG
    Liver Int; 2015 Nov; 35(11):2392-400. PubMed ID: 25689614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
    Petta S; Wong VW; Cammà C; Hiriart JB; Wong GL; Marra F; Vergniol J; Chan AW; Di Marco V; Merrouche W; Chan HL; Barbara M; Le-Bail B; Arena U; Craxì A; de Ledinghen V
    Hepatology; 2017 Apr; 65(4):1145-1155. PubMed ID: 27639088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.